The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
6-(4-((6-ChloroH-imidazo[1,2-a]pyridin-2-yl)methyl)piperazin-1-yl)nicotinonitrile ID: ALA3092413
PubChem CID: 73211886
Product Number: C608887, Order Now?
Max Phase: Preclinical
Molecular Formula: C18H17ClN6
Molecular Weight: 352.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1ccc(N2CCN(Cc3cn4cc(Cl)ccc4n3)CC2)nc1
Standard InChI: InChI=1S/C18H17ClN6/c19-15-2-4-18-22-16(13-25(18)11-15)12-23-5-7-24(8-6-23)17-3-1-14(9-20)10-21-17/h1-4,10-11,13H,5-8,12H2
Standard InChI Key: UGDJVSURAKMIPU-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
1.5463 -3.8754 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5451 -4.6950 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2532 -5.1039 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9629 -4.6945 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9600 -3.8718 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2514 -3.4666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2535 -5.9162 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.5439 -6.3234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5418 -7.1370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2476 -7.5496 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.9572 -7.1424 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9610 -6.3226 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2443 -8.3668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.9503 -8.7782 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0362 -9.5870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.7019 -8.4446 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2463 -9.0540 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.8326 -9.7576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.2350 -10.4656 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0510 -10.4712 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4629 -9.7629 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.0581 -9.0578 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2493 -2.6535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2469 -1.8363 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.2822 -9.7665 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
7 8 1 0
7 12 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 1 0
3 7 1 0
10 13 1 0
13 14 1 0
14 15 1 0
15 18 2 0
17 16 1 0
16 14 2 0
17 18 1 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
23 24 3 0
6 23 1 0
21 25 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 352.83Molecular Weight (Monoisotopic): 352.1203AlogP: 2.58#Rotatable Bonds: 3Polar Surface Area: 60.46Molecular Species: NEUTRALHBA: 6HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 6.12CX LogP: 2.36CX LogD: 2.34Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.72Np Likeness Score: -3.10
References 1. Boehm M, Hepworth D, Loria PM, Norquay LD, Filipski KJ, Chin JE, Cameron KO, Brenner M, Bonnette P, Cabral S, Conn E, Ebner DC, Gautreau D, Hadcock J, Lee EC, Mathiowetz AM, Morin M, Rogers L, Smith A, VanVolkenburg M, Carpino PA.. (2013) Chemical Probe Identification Platform for Orphan GPCRs Using Focused Compound Screening: GPR39 as a Case Example., 4 (11): [PMID:24900608 ] [10.1021/ml400275z ] 2. Burley R, Hewer RC, Teall M, Dickson L, Ossola B, Russell S, Bender C, Cheung T, Powell JAC, Xu X, Brice NL, Otter L, Arimont M, Kidd SL, Vidal D, Dale JW, Mervin L, Sore HF, Mateu N, Lakshminarayana N, Dawson LA, Carlton M, Bürli RW.. (2022) Synthesis and SAR of novel GPR39 agonists and positive allosteric modulators., 61 [PMID:35123006 ] [10.1016/j.bmcl.2022.128607 ]